Northern Mariana Islands Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Northern Mariana Islands Health News.

Press releases published on July 16, 2026

10 hours ago

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Indeterminate GlobeNewswire

11 hours ago

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

Indeterminate GlobeNewswire

11 hours ago

OXB Selected as GMP Manufacturing Partner to Support Manufacturing of Plowshare Therapies’ AAV Gene Therapy Programme

Indeterminate GlobeNewswire

11 hours ago

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

11 hours ago

Gain Therapeutics CEO Gene Mack Issues Letter to Shareholders and Provides Operational Update

Indeterminate GlobeNewswire

11 hours ago

Remix Therapeutics to Present at AACR Drug Discovery and Development Conference

Indeterminate GlobeNewswire

11 hours ago

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025

Indeterminate GlobeNewswire

11 hours ago

Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

12 hours ago

Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

Indeterminate GlobeNewswire

12 hours ago

Zymeworks to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

13 hours ago

4TEEN4 Receives U.S. FDA Fast Track Designation for Invobenitug in Cardiogenic Shock

Indeterminate GlobeNewswire

13 hours ago

Arletta Pharma Solutions Receives FDA Response Supporting the Clinical Development Program of Lybrido™ for Female Sexual Interest/Arousal Disorder in the US

Indeterminate GlobeNewswire

13 hours ago

BienRaíz Launches 240 mg Magnesium Glycinate Supplement, Expanding Its Daily Wellness Portfolio with Targeted Mineral Support

Indeterminate GlobeNewswire

14 hours ago

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

Indeterminate GlobeNewswire

17 hours ago

Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development

Indeterminate GlobeNewswire

17 hours ago

argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026

Indeterminate GlobeNewswire

17 hours ago

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

Indeterminate GlobeNewswire